Lewis Truex is an experienceddrug development professional with expertise in non-clinical safety assessment, toxicology study monitoring, outsourcing, CRO selection, study director responsibilities, infusion procedures, non-clinical regulatory requirements and compliance, mammalian toxicology models, and phototoxicity studies. Mr. Truex spent almost 40 years with Eli Lilly and Company in the areas of neuroscience research and toxicology, providing toxicology support for over 60 targets and writing toxicology study reports, IBs, INDs, and other registration documents for approximately 30 programs.
An American Board of Toxicology (ABT) Diplomate, Mr. Truex has co-authored over 20 papers and has presented at numerous conferences and lectures.
